SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 5 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,627 | -97.2% | 17,135 | -94.3% | 0.00% | – |
| Q1 2023 | $167,853 | +6824.6% | 299,736 | +9049.5% | 0.00% | – |
| Q4 2022 | $2,424 | -91.9% | 3,276 | -75.6% | 0.00% | – |
| Q3 2022 | $30,000 | -74.6% | 13,421 | -64.1% | 0.00% | – |
| Q2 2022 | $118,000 | +24.2% | 37,357 | +88.5% | 0.00% | – |
| Q1 2022 | $95,000 | -1.0% | 19,816 | +83.1% | 0.00% | – |
| Q4 2021 | $96,000 | +2.1% | 10,824 | +64.3% | 0.00% | – |
| Q3 2021 | $94,000 | -96.0% | 6,586 | -96.0% | 0.00% | – |
| Q2 2021 | $2,374,000 | +9396.0% | 164,259 | +8740.6% | 0.00% | – |
| Q1 2021 | $25,000 | -76.0% | 1,858 | -48.2% | 0.00% | – |
| Q4 2020 | $104,000 | – | 3,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 1,330,889 | $984,857 | 0.08% |
| Artal Group S.A. | 1,606,309 | $1,189 | 0.07% |
| Sandy Cove Advisors, LLC | 51,707 | $38,263 | 0.03% |
| MAVERICK CAPITAL LTD | 1,068,155 | $790,435 | 0.02% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,862,708 | 0.01% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $2,041,045 | 0.01% |
| RBF Capital, LLC | 127,930 | $94,000 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 14,000 | $10 | 0.00% |
| Ergoteles LLC | 64,215 | $47,519 | 0.00% |
| Baldrige Asset Management LLC | 5,000 | $4 | 0.00% |